Gadobutrol in Renally Impaired Patients-Reference-Cited by-同舟云学术

Gadobutrol in Renally Impaired Patients

Published:2017-01 Issue:1 Volume:52 Page:55-60
ISSN:1536-0210
Container-title:Investigative Radiology
language:en
Short-container-title:Invest Radiol

Author:

Michaely Henrik J.,Aschauer Manuela,Deutschmann Hannes,Bongartz Georg,Gutberlet Matthias,Woitek Ramona,Ertl-Wagner Birgit,Kucharczyk Walter,Hammerstingl Renate,De Cobelli Francesco,Rosenberg Martin,Balzer Thomas,Endrikat Jan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference28 articles.

1. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients;Lancet,2000

2. Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?;Nephrol Dial Transplant,2006

3. Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis;J Am Acad Dermatol,2007

4. Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations;J Am Acad Dermatol,2011

5. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines;Eur Radiol,2013

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Ln(III) Derivatives as ¹⁹F Parashift Probes;Inorganic Chemistry;2024-05-15

2. Clinical Safety of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations;Investigative Radiology;2024-03-01

3. Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging;Investigative Radiology;2024-02

4. Gadofosveset-Trinatrium-Enhanced MR Angiography and MR Venography in the Diagnosis of Venous Thromboembolic Disease: A Single-Center Cohort Study;Diseases;2022-12-05

5. Safety profile of Gadoterate meglumine on the renal function of patients with severe kidney disease;Clinical Imaging;2022-11